C16 Biosciences

Produces sustainable ingredients for consumer goods

New York City, New York, United States

About C16 Biosciences

C16 Biosciences creates sustainable ingredients for consumer goods, focusing on the beauty, personal care, home care, and food product markets. The company uses a unique biomanufacturing platform to produce ingredients that perform well while being environmentally friendly. This method helps tackle issues like supply and price instability, as well as the rising demand for sustainable products from consumers and regulators. C16 Biosciences primarily serves consumer goods manufacturers, providing them with high-quality ingredients that meet the growing need for effective and eco-friendly products. Operating on a B2B model, the company sells its biodesigned ingredients to these manufacturers, who then incorporate them into their products for consumers. C16 Biosciences aims to lead the effort in making consumer products more sustainable, supporting both environmental health and the needs of its clients.

New York City, New YorkHeadquarters
2018Year Founded
$32.6MTotal Funding
GRANTCompany Stage
Biotechnology, Consumer GoodsIndustries
11-50Employees

Benefits

Unlimited Paid Time Off
401(k) Company Match
401(k) Retirement Plan
Health Insurance
Dental Insurance
Vision Insurance
Mental Health Support

Risks

Increased competition from startups like Nourish Ingredients.
Economic viability of microbial fermentation-based ingredients is uncertain.
Alternative protein space faces financial challenges impacting future funding.

Differentiation

C16 Biosciences uses yeast fermentation to produce oils without arable land.
Their Palmless™ platform offers sustainable alternatives to traditional palm oil.
Torula oil, their first biodesigned ingredient, enhances skin and hair health.

Upsides

Received $3.5M grant from Gates Foundation to expand Palmless™ platform.
Global edible oils market projected to reach $870 billion by 2050.
Awarded World Cell-base Innovation Award for 'Best Cell-based Ingredient'.

Funding

Total raised$32.59 M
Latest valuation$100.00 M
StageGRANT
EARLY VC
12/31/2023
$1
$100.00 M
$20
$100.00 M
$4
$20.00 M